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ABSTRACT 
 
Standard diagnosis of oral cancer is based on visual inspection and palpation by a 
clinician followed by histological examination of one or more tissue biopsies. Choosing 
the right location for biopsies, which represents the most severe lesion, is difficult and 
subjective to each clinician’s experience, especially for precancer lesions which are often 
diffuse, multifocal, and clinically indistinguishable from benign lesions. This may lead to 
low diagnosis sensitivity. The aim of this dissertation is to design a more sensitive and 
objective screening tool to guide the biopsy of oral cancer and precancer.  
Fluorescence lifetime imaging microscopy (FLIM) is a noninvasive optical 
technique which is able to detect the information of tissue metabolism and biochemistry 
based on fluorescence as a source of contrast. Recently, there is increasing interest in the 
application of multispectral FLIM for medical diagnosis. Central to the clinical translation 
of FLIM technology is the development of compact and high-speed clinically compatible 
systems. In this dissertation, four multispectral FLIM systems were designed and built. A 
bench-top multispectral FLIM system was first built and combined with reflectance 
confocal microscopy (RCM) for the preclinical validation by imaging a hamster cheek 
pouch model of oral carcinogenesis. After that, in order to facilitate in vivo imaging of 
human oral mucosa, three different multispectral FLIM endoscopes were designed. The 
first FLIM endoscope was built based on a fiber bundle and the time-gated implementation 
by an intensified charged-coupled device (ICCD). The system was validated by imaging 
a hamster cheek pouch model of oral carcinogenesis. To achieve faster imaging speed and 
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more accurate lifetime estimation, two rigid handheld FLIM endoscopes were built based 
on a pulse sampling implementation. These two handheld endoscopes were different in 
weight and size. The more compact one might serve as the clinical prototype for oral 
cancer and precancer detection. Both systems were validated by imaging the human oral 
biopsy ex vivo and human oral mucosa in vivo. The development of these systems will 
facilitate the evaluation of multispectral FLIM for oral cancer and precancer detection. 
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1. INTRODUCTION  
1.1 Motivation 
Oral Cancer is defined as cancer that forms in the oral cavity or the oropharynx. The 
National Cancer Institute (NCI) estimates that around 42,440 new cases of oral cancer will 
be found in the United States in 2014 [1]. Although the incidence of oral cancer is lower 
than that of some common cancers, it has a lower average five-year survival rate. The 
average five-year survival rate for oral cancer is 62%, compared to 89% of breast cancer, 
99% of prostate cancer and 64% of colorectal cancer [2]. However, when detected in its 
early stage, the five-year survival rate for oral cancer can be improved to 82% [3]. Thus, 
early detection is crucial. 
The late diagnosis of oral cancer can be mainly attributed to the conventional clinical 
diagnosis method, which is based on visual inspection and palpation by the clinician, 
followed by one or more tissue biopsies for histopathological diagnosis. This conventional 
method has some disadvantages. On one hand, premalignant lesions are often 
undistinguishable from benign tissue by visual examination, making it difficult for early 
premalignant detection. On the other hand, since only a few biopsies can be taken, 
sampling errors introduced by the clinicians on choosing the most severe region to present 
the whole lesion is subjective to their experience and will ultimately decrease the diagnosis 
sensitivity.  
The motivation of this study is to design an objective and reliable screening tool to 
help detect oral cancer in an early stage and guide tissue biopsy to avoid underdiagnosis 
and improve diagnosis yield. 
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Various optical imaging techniques are being explored for noninvasively detecting 
epithelial cancers in vivo due to their specific abilities to exploit tissue contrast 
mechanisms, which is called “optical biopsy”. However, most of these optical imaging 
systems are typically designed to either have a macroscopic view, sacrificing spatial 
resolution, or to have a high resolution with a limited field of view (FOV).  
The ideal optical system to help detect carcinoma should have two main capabilities: 
First, the system should be able to conduct multi-scale imaging which is macroscopic 
surveillance guiding high resolution imaging. Second, since there are both biochemical 
and morphological changes during the progression of dysplasia, the system should also be 
able to characterize these changes as the diagnosis criteria. 
To meet these requirements, a multimodal optical system was designed and built by 
our group. The system combined large-field fluorescence lifetime imaging microscopy 
(FLIM) and high-resolution reflectance confocal microscopy (RCM). It performs fast 
macroscopic FLIM surveillance, followed by depth sensitive, high resolution RCM 
imaging for suspicious locations manifested by FLIM. Since FLIM can provide 
information about tissue metabolism and biochemistry based on fluorescence as a source 
of contrast and RCM can detect morphologic changes based on the reflectivity difference 
between cell cytoplasm and nucleus as a source of contrast, we hypothesize that the 
comprehensive information provided by the combined system will increase the diagnosis 
accuracy of oral cancer in its early stage.  
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1.2 Objectives and dissertation organization 
Although the overall aim of this project is to design and build a combined FLIM-
RCM system, the objective for this dissertation is focused on designing, building and 
validating the FLIM subsystem for the combined FLIM-RCM system. Only one chapter 
in this dissertation describes the combined FLIM-RCM system on a bench-top form. The 
following endoscope systems are for FLIM subsystem only.  
In order to build the FLIM subsystem for oral mucosa imaging in vivo, four major 
milestones were achieved. 
First, a bench-top multispectral FLIM system was built to combine with RCM system 
with a translation stage for image co-registration. A preclinical trial on the hamster cheek 
pouch model of oral carcinogenesis was conducted. 
Second, a flexible FLIM endoscope based on a wide-field time-gated implementation 
was built. The system was validated by the hamster cheek pouch model of oral 
carcinogenesis.  
Third, in order to achieve faster imaging speed and more accurate lifetime estimation, 
a rigid handheld multispectral FLIM endoscope was built based on the pulse sampling 
implementation. The clinical study of human oral tissue was conducted ex vivo and in vivo. 
Fourth, based on the feedback from the physicians who used the system, a compact 
version of the handheld endoscope with smaller size and less weight was built.  
The chapters of this dissertation are organized according to the four milestones 
mentioned above: 
 4 
 
In the introduction chapter, the motivation of this study and the organization of the 
dissertation are presented. 
In Chapter 2, Section 2.1 introduces the concepts of fluorescence and fluorescence 
lifetime. Section 2.2 introduces the interested autoflorophores in epithelium and 
connective tissue and their changes associated with dysplasia. Section 2.3 introduces the 
three main implementations to conduct time-domain FLIM. Section 2.4 is a review of 
previously published FLIM endoscopes.  
Chapter 3 focuses on the bench-top combined FLIM-RCM system. The design of the 
system is described in Section 3.1. Validation results of phantom imaging, porcine buccal 
mucosa imaging ex vivo and hamster cheek pouch imaging in vivo are presented in Section 
3.2, 3.3 and 3.4, respectively. Section 3.5 and 3.6 are conclusion and discussion. 
Chapter 4 focuses on the fiber-bundle based FLIM endoscope. The design of the 
system is described in Section 4.1. Validation results of standard dyes and hamster cheek 
pouch imaging in vivo are presented in Section 4.2 and 4.3, respectively. At last, the 
limitations of this system are discussed in detail in Section 4.4 which is the reason for 
designing the rigid handheld FLIM endoscope in Chapter 5 and Chapter 6. 
Chapter 5 focuses on rigid handheld FLIM endoscope. The design of the system is 
described in Section 5.1. Validation results of standard dyes imaging, normal hamster 
cheek pouch imaging in vivo and normal human oral mucosa imaging in vivo are presented 
in Section 5.2, 5.3 and 5.4, respectively. In Section 5.5 and 5.6, results of oral biopsy 
imaging ex vivo and human oral cancer imaging in vivo are presented, respectively. 
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Chapter 6 focuses on the compact version of rigid handheld FLIM endoscope which 
might serve as the clinical prototype for in vivo study in the future. The design of the 
system is described in Section 6.1. Section 6.2, 6.3 and 6.4 present the results of standard 
dye validation, normal human oral mucosa imaging in vivo and oral biopsy imaging ex 
vivo, respectively. 
In Chapter 7, a conclusion is made in Section 7.1. The discussion of the future work 
is presented in Section 7.2. 
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2. FLUORESCENCE LIFETIME IMAGING MICROSCOPY (FLIM) 
2.1 Fluorescence and fluorescence lifetime 
Fluorescence is the emission of light by a molecule which absorbs light or other 
electromagnetic radiation [4]. The absorption of light excites the molecule from its ground 
state to a higher energy state, and its return to the ground state gives rise to fluorescence 
emission. A simplified Jablonski diagram which only consists of two electronic states is 
shown in Fig.1 to demonstrate the generation of fluorescence, in which the ground state is 
labeled as S0 and the first excited electronic state is labeled as S1. In each state, several 
lines are drawn to represent the vibrational energy states within S0 and S1, respectively. 
Absorption happens when the energy of excitation matches the energy difference between 
the lowest vibrational state of S0 and any of the vibrational states of S1. Since there are 
several vibrational states within S1, the absorption spectrum is broad. Likewise, the energy 
of emission equals the difference between lowest vibrational state of S1 and any of the 
vibrational state of S0, resulting in a broad emission spectrum. Because of the vibrational 
relaxation which is a non-radiative process among the vibrational states within S1, the 
emission light has a longer wavelength than that of the excitation.  
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Figure 1: Simplified Jablonski diagram illustrating the various electronic and vibrational 
states of a molecule and the transitions between states. S0: ground state, S1: excited state. 
 
Fluorescence lifetime is defined as the average time the molecule spends in the 
excited state prior to returning to the ground state [4]. The simplest case of a fluorescence 
decay follows a mono-exponential function. In this situation, the lifetime, denoted by τ in 
Eq. 2.1, is the time when the emission drops to 37% of the maximum intensity value I0.  
                                                       𝐼(𝑡) = 𝐼0𝑒
−𝑡/𝜏                                                          (2.1) 
For more complicated samples that have several fluorescent components or follow the 
multi-exponential decay, an average lifetime can be calculated as in Eq. 2.2. 
                                           𝜏 =
∫ 𝑡 𝐼(𝑡)𝑑𝑡
∞
0
∫ 𝐼(𝑡)𝑑𝑡
∞
0
                                                              (2.2) 
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2.2 Intrinsic autoflorophores in oral epithelial tissue 
Autofluorophores in biological tissue have been of particular interest in clinical 
research studies. They can serve as label-free indicators of changes associated with 
dysplasia without the administration of contrast agents. In oral epithelial tissue, there are 
two layers which are divided by the basement membrane: the epithelium layer and 
underlying stroma layer. In the epithelium layer, there are metabolic coenzymes 
nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FAD) inside 
the living cells. In stroma layer, there are collagens and collagen crosslinks. During the 
progression of dysplasia, the morphological and biochemical changes, such as the 
increasing epithelium thickness and metabolism activity, will modulate the tissue 
autofluorescence emission. Increased fluorescence from epithelium due to the increased 
cellular metabolism and decreased fluorescence from stroma due to the breakdown of 
collagen crosslinks, infiltration of lymphocytes, and increased epithelial thickness are 
expected.  
2.3 Methods of conducting the time-domain FLIM 
Fluorescence measurements can be classified into two categories: steady-state and 
time-resolved. The steady-state method usually measures the absolute fluorescence 
intensity or the emission spectrum. Compared to time-resolved measurement, it can be 
achieved by a relative simple implementation and cheaper instrumentation. However, in 
biological tissue study, the overlap of the emission spectrums from different 
autofluorophores makes it difficult to resolve individual autofluorophores from the steady-
state data. Also, steady-state method can be easily affected by some external factors during 
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in vivo imaging, such as the changes in light excitation-collection geometries, presence of 
endogenous absorbers, intensity artifacts caused by variation in tissue surface profile, and 
photobleaching effects [5]. The alternative method, time-resolved or lifetime 
measurement, can address those problems by resolving the sample’s fluorescence decay 
dynamics. Since the lifetime of fluorophore is independent of fluorescence intensity, it is 
more robust for the clinical applications. 
The time-resolved measurement can be performed in either time domain or frequency 
domain. As shown in Fig. 2 (a), in the time-domain measurement, the sample is excited 
by a short pulse of excitation and the emission decay is recorded as a function of time for 
lifetime calculation. In frequency-domain measurement as shown in Fig. 2 (b), the sample 
is excited with intensity modulated light at high frequency. The detected fluorescence 
emission is intensity modulated at the same frequency with a phase shift and a decreased 
modulation depth. The lifetime can be computed by the equations shown in Fig. 2 (b). For 
complex samples which have several lifetime components, different excitation modulation 
frequencies are required to cover the entire fluorescent decay dynamics. 
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Figure 2: Time-resolved measurement techniques. (a) Time-domain FLIM is performed 
by exciting the sample with a short light pulse and the fluorescence decay is used for 
lifetime calculation. (b) Frequency-domain FLIM is performed by exciting the sample 
with an intensity modulated light source (sinusoidal signal with angular frequency ω as 
an example in the figure). The recorded emission signal with phase shift φ and intensity 
modulation m with respect to the excitation signal is used for lifetime calculation. τφ and 
τm are the two lifetimes. 
 
In this dissertation, all the FLIM systems were built based on the time-domain 
measurement. There are three common implementations for time-domain FLIM: time-
correlated single-photon counting (TCSPC), time-gated detection and pulse sampling [5].  
In the TCSPC, a fluorescence decay curve is built as a histogram of the arrival time 
of the first detected photon after each excitation pulse as shown in Fig. 3 (a). At each 
spatial position (pixel), lots of photons are required to build up the histogram. It is 
recommended that 100 and 10,000 photons are needed to get a lifetime estimation 
accuracy of 10% and 1%, respectively. The pixel rate is determined by photon counting 
rate (typically a few MHz, smaller than laser repetition rate of tens of MHz) and total 
photon count per decay which is determined by the requirement for lifetime estimation 
accuracy. To give an example, if 10% lifetime accuracy is acceptable, a frame rate of ~0.6 
Hz can be achieved for a 128 × 128 pixels image at 106 photon counting rate. The 
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advantages of the TCSPC include low required pulse energy, free of gain noise and high 
temporal resolution [6]. These advantages make the TCSPC technique ideal to detect 
minor lifetime changes in live cell study, e.g. forster resonance energy transfer (FRET) 
between molecules.  
For time-gated implementation, the imaging is usually accomplished in wide field by 
a gated intensified charge coupled device (ICCD) as shown in Fig.3 (b). The gate of the 
ICCD opens at specific time to detect the fluorescence intensity. During imaging, a 
sequence of fluorescence intensity images is recorded at specific delays relative to the 
excitation pulse. The fluorescence decay curve for each spatial location is reconstructed 
by the multiple gates in the order of delay time. Since the imaging is in wide field and 
does not require scanning mechanism, it is simple for endoscopy implementation and save 
the time for scanning. However, there are several disadvantages. First, since the excitation 
pulse energy is distributed across the whole FOV, summing and averaging is necessary to 
achieve adequate signal to noise ratio (SNR). Second, in order to achieve higher temporal 
resolution, multiple gates are required to accurately reconstruct a decay curve, which will 
cause longer data acquisition time. Another disadvantage is this method is extremely 
sensitive to motion artifact. The sample cannot be moved during imaging in order to 
correctly reconstruct the fluorescence decay for each spatial position. 
Pulse sampling is the most straightforward time-domain FLIM implementation. As 
shown in Fig. 3 (c), it directly records the fluorescence temporal decay after each 
excitation pulse using high-speed detectors and digitizers. If the pulse energy is high 
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enough to get a decent SNR, only one laser pulse is required for each pixel. Thus, the pixel 
rate equals to the laser repetition rate. By 2-D scanning the sample, an image is achieved. 
 
Figure 3: Time-domain FLIM implementations. (a) TCSPC, the decay curve is 
established as a histogram of the arrival time of the first detected photon for each laser 
pulse. (b) Time-gated detection with an ICCD, a sequence of fluorescence images (from 
I0 (x, y) to In (x, y)) are captured with different delays (multiple times of ∆t) with respect 
to the laser pulse. The gate labeled in the figure is the integration time for each image (c) 
Pulse sampling, the decay is recorded by fast detector (e.g. MCP-PMT). 
 
2.4 Review of previous FLIM endoscopes for in vivo applications 
Many FLIM endoscope designs have already been proposed. Wide-field FLIM 
endoscopy was first demonstrated in the frequency domain [7]. It had a limited spatial 
resolution of 32 × 32 pixels and was validated on human healthy mucosa of the bronchi in 
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vivo. With the development of the gated optical intensifier (GOI), several time-gated 
FLIM endoscopes in time-domain were demonstrated. J. Requejo-Isidro et al. built a rigid 
endoscope with a frame rate of 7.2 Hz. It was validated on a bisected lamb kidney ex vivo 
[8]. I. Munro et al. built a flexible endoscope with a frame rate of 5.5 Hz. The system was 
validated on fresh human stomach and lamb’s kidney tissue ex vivo [9]. G. T. Kennedy et 
al. built a hand-held FLIM system based on a rigid clinical arthroscope and a custom-built 
GOI [10]. Recently, a flexible FLIM endoscope utilizing blue excitation light was 
demonstrated [11]. Compared to UV light, the blue excitation has the advantages of less 
concern on phototoxicity and less unwanted background fluorescence from the optical 
components. However, blue light cannot efficiently excite NADH, which is a very 
important autofluorophore for cancer detection. Besides the designs based on the time-
gated implementation, two flexible endoscopes have been proposed using the TCSPC 
module [12, 13]. Both of them were applied to measure FRET in the live cells and were 
limited to visible wavelength excitation, restricting their use to exogenous fluorescence 
imaging. A common limitation of all these designs mentioned above, however, was the 
acquisition of the fluorescence emission was at a single emission band. Since the 
autofluorophores in biological tissue have distinguished spectrums, multispectral imaging 
will help resolve different autofluorophores.  
For the multispectral FLIM endoscopy, one flexible endoscope design based on a 
wide-field time-gated implementation was proposed. The endoscope design was built 
around a flexible imaging fiber bundle, multispectral imaging was realized by placing a 
filter wheel in the emission optical path, and illumination was delivered using an adjacent 
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multimode fiber [14]. This endoscope was recently used to image oral cancer and brain 
cancer in vivo [15, 16]. However, this design presented three main limitations. First, since 
multispectral imaging was sequential, the time required to record FLIM images at multiple 
emission bands increased with the number of spectral bands. Second, since illumination 
light was delivered through a fiber adjacent to the imaging bundle, achieving uniform 
illumination and endoscope compactness could be challenging. Third, like all the wide-
field time-gated FLIM, in order to achieve a fast imaging speed, a rapid lifetime 
determination (RLD) algorithm had to be adopted which limited the temporal resolution. 
This trade-off between temporal resolution and imaging speed was overcome by several 
FLIM systems based on the pulse sampling implementation stated below. 
A multispectral FLIM catheter was designed and combined with ultrasound imaging 
for intravascular diagnosis [17, 18]. Due to the low repetition rate of the laser source (30 
Hz), the imaging speed was slow. The upgrade version of this system was published later 
with a high repetition rate laser (1 MHz). The system was validated on a swine model of 
pig arteries in vivo. However, the average excitation power they used exceeded the 
maximum permission energy (MPE) set by ANSI, which made it not suitable for human 
in vivo imaging. A hyperspectral FLIM was proposed by Nie et al. [19]. The system was 
capable of performing time-resolved measurements at multiple emission wavelengths with 
high spectral resolution by means of an acousto-optic tunable filter (AOTF) which allowed 
rapid random wavelength switching in the collection path. The system was validated on 
porcine skin specimens ex vivo. However, the reported pixel rate was slow (~3 Hz). 
Yankelevich et al. reported a multispectral time-resolved fluorescence spectroscopy 
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(TRFS) system recently [20]. The imaging speed was 9.6s for 1500 pixel which is still not 
fast enough to avoid motion artifact for in vivo imaging. In addition, both systems in [19] 
and [20] were limited to one single point detection. The beam steering mechanism was 
not integrated, and imaging was achieved by an external stage to move the sample.  
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3. BENCH-TOP COMBINED FLIM-RCM SYSTEM 
3.1 Bench-top combined FLIM-RCM system 
In order to determine specific design parameters for the endoscope system and 
characterize the system’s performance for detecting oral precancer and cancer, a bench-
top combined FLIM-RCM system was built before endoscope designs [21].  
In the multi-scale multimodal FLIM-RCM system, FLIM is used to provide real-time 
macroscopic images of the biochemical makeup of the specimen. These images then serve 
as a guide to direct RCM to suspicious sites within the FOV. Co-registered RCM 
facilitates morphological imaging of the sub-cellular structure of the epithelium with small 
FOV, but very high spatial resolution in three dimensions. The greatest contrast source of 
RCM in the epithelium is the variation in tissue refractive index, for example, the cell 
nuclei compared to the surrounding cytoplasm [22]. This enables visualization of cell 
nuclei and quantification of the features such as the nuclear-to-cytoplasmic ratio. The 
nuclear-to-cytoplasmic ratio is one of the morphological features for diagnosis of oral 
epithelial dysplasia and oral squamous cell carcinoma [23].  
The multimodal optical system is designed to probe the biochemical properties of 
tissue on a macroscopic scale and the cellular morphology with a high resolution. 
Therefore, a large-field FLIM and a high-resolution RCM subsystems are placed 
adjacently with a common sample translation stage for co-registration of images. A 
                                                 
 Reprinted with permission from “Fluorescence lifetime imaging and reflectance confocal microscopy for 
multiscale imaging of oral precancer” by Jabbour. J.M., Cheng S., Malik B.H., Cuenca R., Jo J.A., Wright 
J., Cheng Y-S.L., Maitland K.C., 2013. Journal of Biomedical Optics, 18(4), p. 046012, Copyright [2013] 
by Society of Photo-Optical Instrumentation Engineers. 
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detailed schematic of our integrated system is shown in Fig. 4. For FLIM subsystem, a 
frequency-tripled Q-switched ND: YAG laser (355 nm, <1ns pulse duration, 100 kHz 
maximum repetition rate, AOT-YVO-100QSP/MOPA, Advanced Optical Technology) 
was used as excitation. The laser light was coupled into a multimode fiber with a core 
diameter of 50 µm (FVP050055065, Polymicro Technologies) and delivered to the bench-
top system. The output of the excitation fiber was collimated and then reflected by a 
dichroic mirror (DM1: NC176741-z355rdc, Chroma) to a pair of galvanometer mirror 
scanners (6200HM40, Cambridge Technology) for two-dimensional raster scanning. A 
UV-NIR corrected triplet (f=45mm, NT64-837, Edmunds Optics) was used to focus light 
in the sample. The fluorescence emission was collected by the same triplet and passed the 
dichroic mirror (DM1) to the collection fiber with a core diameter 200 µm (BFL22-200, 
Thorlabs). The output of the collection fiber was launched to a multispectral detection unit 
which consisted of dichroic mirrors (DM2: T>95%@439-647 nm, LM01-427-25, DM3: 
T>95%@492-950 nm, FF484-Fdi01, Semrock), bandpass filters (F1: FF01-390/40, F2: 
FF01-452/45, Semrock), a long pass filter (F3: FF01-496, Semrock) and three multimode 
fibers with lengths of 1m, 13m and 25m (BFL22-200, Thorlabs). The detection unit 
separated the fluorescence emission into three spectral bands which were selected based 
on emission spectrum of the three endogenous fluorophores of interest: collagen (F1: 390 
± 20 nm), NADH (F2: 452 ± 22.5 nm) and FAD (F3: >500 nm). The three multimode 
fibers with different lengths provided a time delay of 60ns with 12 meter length difference 
and helped temperately separate the signals from the three spectral bands. Therefore, for 
each laser pulse, three fluorescence decays for three spectral channels could be detected 
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simultaneously with one single detector. The outputs of the three fibers were then detected 
by a high-speed micro-channel plate photomultiplier tube (MCP-PMT, 180 ps rise time, 
90 ps transit time spread, R5916U-50, Hamamatsu), amplified by a preamplifier (C5594-
12, Hamamatsu) and sampled by a digitizer at 6.25 GHz (PXIe-5185, National 
Instruments) using custom software programmed in LabVIEW (National Instruments). 
The FLIM data was then processed with MATLAB (Mathworks, Natick, MA). For each 
sample, nine maps were generated: three absolute intensity maps (I1, I2 and I3), three 
normalized intensity maps (I1n, I2n and I3n) and three average lifetime maps (τ1, τ2 and τ3) 
for three spectral channels, respectively. The I1, I2 and I3 were the time-integrated intensity 
values at corresponding pixels in the 390 nm, 452 nm, and >500 nm spectral bands, 
respectively. The I1n, I2n and I3n were calculated by I1n=I1/(I1+I2+I3), I2n=I2/(I1+I2+I3), 
I3n=I3/(I1+I2+I3) to show the proportion of each spectral channel among the three spectral 
channels. To calculate average lifetime, the measured fluorescence decays were first 
deconvolved from instrument response function (IRF) using the Laguerre deconvolution 
method to get real intrinsic fluorescence decays. The average lifetime τave was then 
calculated from the intrinsic fluorescence decay h(t) with ( ) ( )ave t h t h t    , where t 
is time. 
This bench-top FLIM subsystem had a field of view (FOV) of 16×16 mm2 while 
being able to distinguish element 1 of group 3 of USAF target corresponding to a lateral 
resolution of 62.5 µm using 400×400 pixels per image. For each pixel, only one pulse with 
a pulse energy of 1 μJ/pulse was used. The generated fluorescence signal had a decent 
signal to noise ratio (SNR) and no average was applied. As a result, the pixel rate was 
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equal to laser repetition rate. The acquisition of one single image took 19.2 s with 400×400 
pixels at 10 KHz laser repetition rate. The frame rate was varied depending on the number 
of pixels per frame and the laser repetition rate. The temporal resolution was calculated to 
be 320 ps based on the Nyquist theorem with 6.25 GS/s sampling rate. 
For the RCM subsystem, a near infrared (NIR) continuous wave diode-pumped 
solid state laser (1064 nm, 1 W, CL1064-1W0, Crystalaser, Reno, NV) was used as the 
illumination source. A combination of a half-wave plate and a linear polarizer in the beam 
path served as a variable attenuator to control the optical power incident on the sample. A 
spatial filter in the beam path was used to produce a clean Gaussian beam. An 8 kHz 
resonant scanner and a galvanometer scanner operating at 7 Hz (CRS 8K and 6215HM40, 
Cambridge Technology) were close-coupled to raster scan the NIR beam. A 2× beam 
expander filled the back aperture of a water immersion objective lens (60×, 1.0 NA, 2 mm 
working distance, LUMPLFLN60X/W, Olympus, Center Valley, PA), which focused the 
light onto the sample. A combination of linear polarizer, polarizing beam splitter, and 
quarter wave plate were used to remove specular reflections within the optical system. 
Finally, a spatial filter with a confocal pinhole of 30 µm diameter for optimized system 
characterization and 50 µm diameter for tissue imaging rejected the out of focus light prior 
to signal detection by an avalanche photodiode (APD) module (APD110C, Thorlabs).  
The RCM subsystem was measured to have a 400 μm diameter FOV and a lateral 
resolution of 0.97 μm. The FWHM axial resolution was measured to be 3.5 μm and 4.5 
µm using 30 µm and 50 µm diameter pinholes, respectively. The larger pinhole was used 
for imaging tissue samples in order to increase signal to noise ratio. 
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 An automated translation stage was used to move the sample between the FOVs 
of the FLIM and the RCM subsystems which were approximately 90 mm apart. A 1951 
positive USAF resolution target placed on a white paper was used to acquire co-registered 
images from the two subsystems with lateral accuracy less than the FLIM lateral resolution.  
 
 
Figure 4: Schematic of the combined FLIM-RCM system. Left: FLIM subsystem. DM: 
Dichroic mirror, F: Filter, PD: Photodiode, BS: Beam splitter, L: Lens. OL: Objective 
lens. Right: RCM subsystem. PH: Pinholes, APD: Avalanche photodiode, HWP: Half 
wave plate, POL: Polarizer, QWP: Quarter wave plate, PBS: Polarizing beam splitter. 
An XYZ translation stage co-registers FLIM and RCM images. 
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3.2 Tissue phantom imaging 
The first step to validate the system was tissue phantom imaging. A two-layer tissue 
phantom was developed to test the system’s capability to detect the macroscopic 
biochemical and microscopic morphological properties of a relatively complex sample. 
The phantom was produced with a thin top layer of 100-120 µm consisting of polymer 
beads to model the epithelial nuclei. NADH and FAD (Sigma-Aldrich) were also added 
to the top layer to mimic autofluorescent metabolic coenzymes in the epithelium. The 
NADH powder was concentrated towards the center and FAD was uniformly distributed 
throughout this layer. The top layer was set on top of a thick lower layer of collagen matrix 
which represented of stroma layer. In order to get a homogenous collagen matrix, collagen 
solution (rat tail tendon type I collagen, BD Biosciences) was used instead of collagen 
fiber. The dissolved collagen solution was added to 10× phosphate buffered saline (PBS) 
solution and 1 M sodium hydroxide (NaOH) along with deionized water. The solution was 
allowed to gel at 37
o
C for 30 minutes. However, the collagen gel was later found to have 
minor fluorescence under 355nm which was our excitation wavelength. The tissue 
phantom samples were prepared in a 96-well plate. The diameter of the wells was 
measured to be ~7 mm. The FLIM FOV was adjusted accordingly to capture a single well 
within the image.    
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Figure 5: FLIM-RCM images of the two-layer phantom. FLIM normalized intensity 
maps at spectral channels of (a) 452±22.5 nm (b) >500 nm, and FLIM average lifetime 
maps and lifetime histograms at (c) and (e) 452±22.5 nm and (d) and (f) >500 nm, 
respectively. RCM images at (g) 32 µm and (h) 60 µm depths. Scale bar in (a) is 2 mm 
for FLIM and in (e) is 50 µm for RCM. 
 
2mm 
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Fig. 5 shows the result of the phantom imaging. Since the collagen gel was found to 
be nearly non-fluorescent at 355 nm excitation, the signal in the 390 nm channel is less 
than 5% relative to the 452 nm and >500 nm channels. Therefore, images are shown only 
for the 452 nm (Fig. 5 (a) and (c)) and >500 nm (Fig. 5 (b) and (d)) bands corresponding 
to NADH and FAD emission, respectively. The circular mask shown in Figs. 5 (a) - (d) is 
the boundary of the phantom well in the 96-well plate. At 355nm excitation, peak emission 
wavelengths for NADH and FAD are around 450 nm and 520 nm, respectively. Part of 
the NADH fluorescence signal may be detected in the FAD band, whereas FAD 
fluorescence is limited to the >500 nm band. Fig. 5 (a) and (b) show FLIM normalized 
intensity maps at 452 nm and >500 nm bnads. The center of the phantom, where both 
NADH and FAD are present, provides fluorescence signal in both spectral channels (0.48 
± 0.08 a.u. in 452 nm band, and 0.45 ± 0.08 a.u. in >500 nm band). At the periphery of the 
phantom, the overall signal is dominated by FAD fluorescence in the >500 nm spectral 
channel (0.88 ± 0.09 a.u.). The known average lifetimes for unbound NADH and FAD are 
approximately 0.5 ns and 2 – 2.5 ns, respectively [24].  Fig. 5 (c) and (d) are the average 
lifetime maps, and Fig. 5 (e) and (f) are the corresponding lifetime histograms. As shown 
in the figures, the average lifetime for the center of the phantom in the 452 nm channel is 
0.32 ± 0.15 ns corresponding to the lifetime of unbound NADH. The average lifetime in 
the >500 nm channel is 2.08 ± 0.15 ns at the periphery which represents FAD, and 1.72 ± 
0.14 ns in the center which is the lifetime combination of NADH and FAD. Fig. 5(g) and 
5(h) show the confocal images from the top-layer of the tissue phantom at depths of 
approximately 30 µm and 60 µm, respectively. The polystyrene beads appear as white 
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dots in the reflectance images, and are fairly uniformly distributed over the entire FOV. 
These results demonstrate that such a two-layer phantom is well-suited to validate our 
dual-modality imaging system.  
3.3 Porcine buccal mucosa imaging ex vivo 
Porcine buccal mucosa was used as a model of human oral mucosa due to their similar 
epithelial thickness. Healthy porcine tissue was obtained from a local slaughterhouse or 
through the tissue sharing program at Texas A&M University, and transported to the lab 
for imaging within a couple of hours postmortem. 2×2.5 cm2 buccal mucosa tissue samples 
were excised from the inner cheek and placed in PBS solution prior to imaging. The pig 
tissue was at room temperature (~70ºF) during imaging.  
Fig. 6 shows the result of the porcine buccal mucosa imaging ex vivo. The normalized 
intensity maps (Fig. 6 (a) - (c)) indicates slightly stronger fluorescence signal in the 452 
nm band (0.42 ± 0.02 a.u.), followed by the >500 nm band (0.31 ± 0.03 a.u.) and 390 nm 
band (0.27 ± 0.02 a.u.). The weak signal in the collagen channel (390nm channel) may be 
due to the thick epithelium, which makes it difficult for the fluorescence from collagen to 
reach the surface of the tissue. The thickness of the epithelium is more than 400 µm as 
shown in the H&E histology images in Fig. 6 (j). The average lifetime images (Fig. 6 (d) 
- (f)) show relatively longer values at 390 nm (5.84 ± 0.49 ns), followed by >500 nm (5.09 
± 0.41ns) and 452 nm (4.26 ± 0.41 ns) channels. Both intensity and lifetime maps are 
homogeneous, as expected in normal tissue. The RCM images in Fig. 6 (g)-(i) clearly 
shows the epithelial cell nuclei as bright spots on a darker background. Both the nuclear 
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density and nuclear-to-cytoplasmic ratio increase with depth in the epithelium, which is a 
hallmark of normal epithelium.  
3.4 Preclinical in vivo imaging of a hamster cheek pouch model of oral cancer 
The hamster cheek pouch model of oral cancer was employed to evaluate the 
system’s performance to differentiate dysplasia from normal tissue. Specifically, the 
hamster was imaged during the early stages of 7,12-dimethylbenz [α] anthracene 
(DMBA)-induced oral carcinogenesis. A Golden Syrian hamster was used in this study. 
The animal use protocol was reviewed and approved by the Texas A&M University 
Institutional Animal Care and Use Committee (IACUC), and a veterinarian oversaw the 
clinical aspects of this study. The hamster was housed in pathogen-free conditions and fed 
with rodent chew and water ad libitum. The right buccal pouch of the hamster was treated 
3 times a week for 8 weeks with 0.5% solution of DMBA (Sigma-Aldrich) dissolved in 
mineral oil (Sigma-Aldrich). The left pouch was treated with mineral oil only and served 
as a normal control. At the time of imaging, the hamster was anesthetized using an 
intraperitoneal injection of 10% urethane solution. Once anesthetized, the hamster cheek 
pouch was pulled and clamped into a custom built mount to expose maximum tissue area. 
During the imaging procedure, the anesthetized hamster was kept warm with a heating 
pad. The exposed cheek pouch was likely between room temperature and body 
temperature of the hamster. After imaging of the buccal mucosa, the hamster was 
euthanized with a solution of pentobarbital. The cheek pouches were then excised, fixed 
in 10% formalin, and processed for H&E histology.  
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Figure 6: Ex vivo FLIM-RCM images of the normal porcine buccal mucosa. Normalized 
intensity maps at (a) 390±20nm, (b) 452±22.5nm, and (c) >500 nm. FLIM average 
lifetime maps at (d) 390±20nm, (e) 452±22.5nm, and (f) >500 nm. Arrows in (a) - (f) 
identify the RCM imaging location at the center of the FLIM FOV. RCM images 
obtained at (g) 60 µm, (h) 120 µm, and (i) 190 µm depths. Arrows in (g) - (i) point to 
individual nuclei. (j) 10× H&E histology image of tissue. Scale bar is 2 mm in (a), 50 
µm in (g), and 100 µm in (j).  
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Fig. 7 and Fig. 8 show the results for the normal and the DMBA-treated hamster 
cheek pouch, respectively. Fig. 7 (a)-(f) show the normalized fluorescence intensity and 
average lifetime maps for the normal hamster cheek pouch. The normalized fluorescence 
intensity values are 0.42 ± 0.04 a.u., 0.3 ± 0.01 a.u., and 0.28 ± 0.03 a.u., and lifetimes 
values are 5.61 ± 0.13 ns, 4.06 ± 0.25 ns, and 4.22 ± 0.29 ns for the 390 nm, 452 nm, and 
>500 nm bands, respectively. These results are consistent with a dominant collagen 
fluorescence emission that peaks at 390 nm and has an average lifetime of 5-6 ns. This is 
expected for the normal hamster cheek pouch, since the epithelium is very thin as shown 
in Fig. 7 (k) and most of the autofluorescence emission should come from collagen in the 
connective tissue. In comparison to the weak collagen signal in the thick porcine buccal 
mucosa, the fluorescence intensity in the 390 nm band is relatively high in the hamster 
cheek pouch tissue due to the very thin epithelium. The RCM images taken from the center 
of the FLIM FOV at approximate depths of 18 µm (Fig. 7 (h)) and 39 µm (Fig. 7 (i)) show 
scattering from the keratin at the surface, and epithelial nuclei beneath this superficial 
layer. Fig. 7 (j) is a zoomed in view of Fig. 7 (i) to more clearly show the cell membranes 
and nuclei identified by arrows. 
Fig. 8 (a)-(f) show the normalized fluorescence intensity and the average lifetime 
maps for the DMBA-treated hamster cheek pouch. As seen in the corresponding 
photograph of the tissue in Fig. 8 (g) and in the FLIM images, a tumor is visible in the 
lower right quadrant of the tissue. In each FLIM map, two locations are marked by arrows 
labeled as Region 1 and Region 2. Region 1 was later diagnosed as cytologic atypia as 
shown in Fig. 8 (h) and Region 2 was diagnosed as low-grade dysplasia as shown in Fig. 
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8 (i) by histopathology. In these lesions, the fluorescence lifetime in the 452 nm channel 
is shorter (4.32 ± 0.18 ns and 4.29 ± 0.29 ns in Regions 1 and 2, respectively) compared 
to the normal tissue (>5 ns). Since NADH has a much shorter fluorescence lifetime (~0.5 
ns) and its peak emission is at 450 nm, the resulting fluorescence in the pre-cancerous 
lesions is expected to have shorter lifetimes at 452 nm than in normal tissue. In the tumor 
region, the epithelium is so thick that all the fluorescence contribution is coming from this 
layer. Since the collagen in the connective tissue is either deconstructed or no longer 
excited due to the increasing epithelial thickness, the signal at 390 nm is insignificant (0.06 
± 0.03 a.u.). Strong emission is observed at >500 nm (0.75 ± 0.14 a.u.) and significant 
emission is also observed at 452 nm (0.19 ± 0.11 a.u.) in the tumor region. The extremely 
low signal in 390 nm band in the tumor region results in inaccurate lifetime measurements; 
therefore, the lifetime map in Fig. 8 (d) is masked in this tumor region. The fluorescence 
lifetime at 452 nm is much shorter (2.62 ± 0.79 ns) compared to normal tissue indicating 
a greater fluorescence contribution from NADH. The fluorescence lifetime in the 500 nm 
channel is longer (5.62 ± 1.27 ns) compared to normal tissue indicating contribution of 
both FAD and porphyrin; porphryin has relatively long lifetime (>6 ns) [15]. The RCM 
images of Region 1 just below the surface (Fig. 8 (j)) and deeper in the epithelium (Fig. 8 
(l) and Fig. 8 (m) zoomed in) show very small features that may be epithelial nuclei or 
possibly nucleoli that can be seen in the corresponding histology section in Fig. 8 (h). In 
contrast, the RCM images of the epithelium in Region 2, shown in Fig. 8 (n), 8 (m) and 
Fig. 8 (o) zoomed in, show much larger nuclei indicative of precancerous changes. Arrows 
in RCM images identify cell nuclei.  
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Figure 7: In vivo FLIM-RCM images of normal hamster cheek pouch. Normalized FLIM 
intensity maps at (a) 390±20nm, (b) 452±22.5nm, and (c) >500 nm. FLIM average 
lifetime maps at (d) 390±20nm, (e) 452±22.5nm, and (f) >500 nm. (g) Photograph of 
imaging areas. RCM images (h and i) taken at different depths below the surface. Zoom 
in RCM image (j) taken from dotted squares in (i).  Arrows in RCM images point to 
individual nuclei. (k) 25× H&E histology image. Scale bar is 2 mm in (a) and 50 µm in 
(k). 
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Figure 8: In vivo FLIM-RCM images of the DMBA-treated hamster cheek pouch. 
Normalized FLIM intensity maps at (a) 390±20nm, (b) 452±22.5nm, and (c) >500 nm. 
FLIM average lifetime maps at (d) 390±20nm, (e) 452±22.5nm, and (f) >500 nm. (g) 
Photograph of imaging areas. (h) and (i) 25× H&E histology images for region 1 
(cytologic atypia) and region 2 (low-grade dysplasia), respectively. RCM images (j, l, n 
and o) taken at different depths below the surface. Arrows labeled 1 and 2 in the FLIM 
images in (a-f) correspond to regions for subsequent RCM images in (j-m) and (n-p), 
respectively. Zoom in RCM images (m and p) taken from dotted squares in (l and o) 
respectively.  Arrows in RCM images point to individual nuclei. Scale bar is 2 mm in (a) 
and 50 µm in (h). 
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3.5 Discussion 
This work shows that our dual-modality multispectral FLIM and RCM imaging 
system can effectively image biochemical and morphological features in tissue. While 
large-field FLIM enables fast macroscopic tissue evaluation, it lacks the ability to provide 
optical sectioning and high spatial resolution for cellular evaluation. The RCM subsystem 
can provide much higher spatial resolution and optical sectioning necessary for cellular 
imaging but has a limited FOV. The combination of these two imaging techniques on a 
single platform offers an important and powerful tool utilizing the strengths of the 
individual subsystems. The complementary information acquired from the integration of 
the two modalities is important for the study of biological changes such as those seen in 
the progression of early cancer. 
In all instances, FLIM imaging provides macroscopic biochemical maps which 
represent the relative contribution of the endogenous fluorophores, both with respect to 
fluorescence intensity and lifetime. While the FLIM images of the tissue phantom show 
some physical features due to the geometry of the phantom and the distribution of NADH 
and FAD, the images of the biological samples showed differences in intensity and 
lifetime signals between normal and cancer. The FLIM maps of healthy pig mucosa are 
relatively homogeneous, as expected, due to the uniform nature of the normal tissue. The 
detected collagen signal from the pig mucosa with thick epithelium and the clear nuclei 
seen with RCM at different depths of tissue demonstrate the potential for translation to 
human oral tissue. Normal human oral mucosa, with an epithelial thickness ranging from 
190 to 580 µm depending on the site in the oral cavity and cell nuclear diameters on the 
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order of 10 µm, has similar tissue architecture and cell morphology to pig oral mucosa 
[25]. In comparison, the hamster tissue has a wide range of pathologies, resulting in spatial 
features in both the intensity and lifetime images. Additionally, the spectral and lifetime 
data of the DMBA-treated pouch is different than the normal control pouch, indicating the 
ability to detect precancerous changes. By comparing the normalized intensity and average 
lifetime values in Table 1, differentiation between normal and tumorous tissue may be 
achieved with intensity measurements alone. However, based on some similarity in 
normalized intensity values and differences in lifetimes between normal tissue and the 
DMBA-treated RCM Regions 1 and 2, the more challenging and relevant problem of 
distinguishing between benign and precancerous lesions may be realized with FLIM. It 
should be noted that the histopathological difference between the normal and pre-
cancerous lesions being compared are very subtle; yet, difference in the FLIM signal could 
already be observed. Nevertheless, the high resolution of RCM is still necessary for 
identifying cellular changes indicative of precancer. 
The results from the high-resolution reflectance confocal microscope demonstrate 
the potential of the imaging system towards characterization of sub-cellular morphological 
features of the epithelial tissue. The brighter nuclei against the darker background can be 
delineated in the RCM images. The normal cell nuclei in the porcine tissue are on the same 
scale as the normal human epithelial cell nuclei. Although the normal hamster epithelial 
nuclei are smaller, they are still detectable with our RCM imaging system. An increase in 
nuclear size is distinguished between normal and dysplastic tissue in hamster cheek pouch. 
RCM images of the epithelial nuclei can be further analyzed either manually or through 
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automated image processing to calculate more objective parameters defining epithelial 
tissue characteristics such as nuclear size, nuclear density and nuclear-to-cytoplasmic ratio 
[26]. The RCM system was able to distinguish between two pathologically different 
regions that look similar using FLIM. This shows the importance of these two 
complementary techniques.  
 
Table 1 Normalized fluorescence intensity and average lifetime for phantom, normal 
porcine mucosa, normal hamster cheek pouch and DMBA-treated hamster cheek pouch 
Sample 
λem 390 nm 452 nm >500 nm 
 Intensity Lifetime Intensity Lifetime Intensity Lifetime 
Phantom 
Center -- 0.48 ± 0.08 0.32 ± 0.15 0.45 ± 0.08 1.72 ± 0.14 
Outer -- -- 0.88 ± 0.09 2.08 ± 0.15 
Normal 
Pig 
Entire 
FOV 
0.27 ± 0.02 5.84 ± 0.49 0.42 ± 0.02 4.26 ± 0.41 0.31 ± 0.03 5.09 ± 0.41 
Normal 
Hamster 
Entire 
FOV 
0.42± 0.04 5.61 ± 0.13 0.30 ± 0.01 4.60 ± 0.25 0.28 ± 0.03 4.22 ± 0.29 
DMBA-
Treated 
Hamster 
Tumor 0.06 ± 0.03 5.43 ± 0.14 0.19 ± 0.11 2.62 ± 0.79 0.75 ± 0.14 5.62 ± 1.27 
Region 
1 
0.49 ± 0.02 5.49 ± 0.16 0.28 ± 0.01 4.32 ± 0.18 0.23 ± 0.02 4.23 ± 0.21 
Region 
2 
0.42 ± 0.02 5.43 ± 0.14 0.27 ± 0.01 4.29 ± 0.29 0.30 ± 0.01 5.16 ± 0.34 
 
3.6 Conclusion 
In summary, we have presented the design and development of a dual-modality 
multi-scale bench-top FLIM-RCM imaging system applied to the characterization of oral 
epithelial tissue. The integrated system is capable of identifying both morphological 
features and the biochemical composition of mucosal tissue, which together can 
potentially serve as a powerful diagnostic aid towards classification of pathological 
condition of the tissue. Such a simultaneous characterization of tissue physiology may be 
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used to assess if the sample is normal, benign, premalignant or malignant, and may 
ultimately be used as a guiding tool for standard screening and intervention methods.  
We are currently evaluating the system described here for differentiation of 
precancer from benign lesions in the hamster cheek pouch model. Following validation of 
this technology in an animal model and in human biopsies, the system can be miniaturized 
for in vivo imaging in humans using lens relays, fiber bundles, and miniature lenses. 
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4. FLEXIBLE MULTISPECTRAL FLIM ENDOSCOPE 
4.1 Flexible multispectral FLIM endoscope system 
In order to translate the FLIM technique to the clinical arena, an endoscope or probe 
based design to access the oral cavity is required. To this effect, a compact FLIM 
endoscope based on fiber-bundle capable of simultaneous multispectral FLIM imaging at 
an imaging speed of ~2 fps was developed [27].  
The system was built based on wide-field time-gated detection implementation. The 
system schematic is shown in Fig. 9. Since tissue endogenous fluorescence is best excited 
with UV light, a frequency-tripled Q-switched Nd:YAG laser was used as the excitation 
source (355nm, <1ns pulse duration, maximum repetition rate of 100KHz, AOT-YVO-
100QSP/MOPA, Advanced Optical Technology). The endoscope was built around an 
imaging fiber bundle suitable for UV-VIS light transmission (10,000 elements, NA of 
0.22, 1.1mm active area diameter, 1 m long, FIGR-10, Fujikura). A Lithium-based GRIN 
lens (Gradient Index lens, NA of 0.2, 1 mm diameter, GRINTECH) was placed at the 
distal end of the bundle with an air gap. Although the air gap gave rise to a loss of laser 
power from air-lens interface, it eliminated the background autofluorescence introduced 
by the glue which could corrupt the signal. A metal tube was used to connect the fiber 
bundle and the GRIN lens and to serve as a protective housing for the endoscope tip. The 
GRIN lens provided a working distance of 5 mm and a circular FOV of 2.25 mm in 
                                                 
 Reprinted with permission from “Flexible endoscope for continuous in vivo multispectral fluorescence 
lifetime imaging” by Cheng S., Rico-Jimenez J.J., Jabbour J., Malik B.H., Maitland K.C., Wright J., 
Cheng Y-S.L., Jo J.A., 2013. Optics Letters, 38(9), p. 1515-1517, Copyright [2014] by The Optical 
Society. 
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diameter (2.25 × magnification). A dichroic mirror (DM1: NC176741-z355rdc, Chroma), 
placed at the proximal end of the imaging bundle, was used to reflect the laser beam into 
the fiber bundle and transmit the fluorescence emission to the detection arm. The laser 
beam size was allowed to be slightly larger than the active area of the bundle to achieve 
relative uniform illumination at the cost of coupling efficiency (~35%). The proposed 
endoscope design thus allowed both small diameter and uniform illumination.  
 
Figure 9: Schematic of the multispectral FLIM endoscope system. BS: Beam sampler, 
DM: Dichroic mirror, M: Mirror, F: Filter, L: Lens. 
 
Wide-field time-gated FLIM was implemented using an intensified charge-coupled 
device (ICCD camera, 200-800 nm spectral range, 14.4 x 10.8 mm2 active area, minimum 
200 ps gate width, 33.8 Hz frame rate, 4Picos, Stanford Computer Optics). Simultaneous 
multispectral FLIM was implemented as follows: based on a similar approach previously 
proposed by Siegel et al. [28]. The fluorescence emission exiting the proximal end of fiber 
bundle was first collimated by an achromatic lens (L1: f=35 mm, Thorlabs). Then, a 
combination of two dichroic mirrors and one reflective mirror (DM2: T>95%@439-
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647nm, DM3: T>95%@492-950nm, Semrock, M1: Ravg>97.5%@450-2000 nm, 
Thorlabs) with three band pass filters (F2: 390±20 nm, F3: 450±20 nm, F4: 560±20 nm, 
Semrock) were used to separate the fluorescence emission into three spectrally resolved 
collimated beams. Each beam was then directed and focused on different regions of the 
active area of the ICCD by means of three reflective mirrors (M2: Ravg>90% from 250 - 
450 nm, M3-4: Ravg>97.5%@450-2000 nm, Thorlabs) and an achromatic lens (L2: f=150 
mm, Thorlabs). The three spectral channels were selected based on the peak emission of 
three fluorophores of interest (collagen, NADH and FAD); however, they can be 
customized for a given specific application. The lateral resolution in all three spectral 
channels was measured to be ~35µm by imaging a USAF resolution target (NT57-895, 
Edmund Optics). 
The fluorescence lifetime maps were obtained by three methods: the rapid lifetime 
determination (RLD) with 2-gate protocol [29], the 4-gate protocol with a linearized least-
squares lifetime determination method [30] and 20-gate method. The 2-gate protocol 
requires only two time-gated fluorescence images recorded at different delays with respect 
to the excitation pulse whereas the 4-gate and 20-gate methods require 4 and 20 time-
gated images, respectively. The 2-gate and 4-gate methods treat the fluorescence decays 
as single exponentials, which is seldom the case for tissue autofluorescence. Nevertheless, 
the approximated average lifetime can still provide fluorescence lifetime contrast in 
biological tissue. The 2-gate method in our wide-field FLIM system allows an imaging 
speed of ~1 fps compared to ~0.5fps and ~0.1fps for 4-gate and 20-gate methods, 
respectively. Although in principle the frame rate for the 2-gate method should be faster 
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and equal to half of the frame rate of the ICCD (33.8 Hz), the time required to change the 
delays between gates at each consecutive frame is still too long (~500 ms) with the current 
control software of the ICCD.  
4.2 Standard dyes validation 
The FLIM endoscope was first validated with a set of three quartz capillary tubes 
loaded with 1 mM solutions of POPOP (in ethanol), NADH and FAD (both in PBS). The 
lifetime estimations from the three methods are listed in Table 2.  
 
Table 2 Comparison of the lifetime estimation with 2-gate, 4-gate and 20-gate methods  
(unit: ns) 
 390nm 450nm 560nm 
 POPOP NADH POPOP FAD 
2-gate 0.93  ±0.21 0.51  ±0.06 1.07  ±0.24 2.32  ±0.56 
4-gate 0.95  ±0.17 0.63  ±0.07 1.09  ±0.19 2.35  ±0.54 
20-gate 1.50  ±0.11 0.55  ±0.07 1.60  ±0.20 2.49  ±0.11 
 
As shown in Table 2, the 2-gate method provides smaller values than the 20-gate 
method, which is expected under the assumption that the fluorescence decays follow 
single exponential decays. However it does provide lifetime contrast among the three 
fluorescent dyes. Since the 4-gate and 20-gate methods take longer time and are not 
suitable for in vivo application, they were not adopted for the later studies in this chapter. 
In Fig. 10, the fluorescence intensity and average lifetime images from the three spectral 
channels with the 2-gate method are shown. As can be seen in Fig. 10 (a), strong emission 
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from POPOP is observed in both the 390±20 nm and 450±20 nm bands, while NADH and 
FAD emission is only observed in the 390±20 nm and 560±20nm bands, respectively. As 
shown in Fig. 10 (b), the average lifetime for POPOP, NADH, and FAD are estimated to 
be 1.07±0.24 ns, 0.51±0.06 ns, and 2.32±0.56 ns, respectively. The results from the three 
FLIM channels are in good agreement with the emission spectrums and lifetimes of the 
three fluorophores in literatures [24, 31, 32]. 
 
Figure 10: In vitro validation imaging of quartz capillaries loaded with (top to bottom) 
NADH, FAD, and POPOP. (A) Fluorescence intensity maps (B) Lifetime maps 
(colorscale in ns).  
 
In order to demonstrate the system’s potential for in vivo applications, continuous 
multispectral imaging was performed whereby two quartz capillary tubes loaded with 1 
mM solutions of POPOP (in ethanol) and NADH (in PBS) were continuously imaged. A 
 40 
 
total of ten consecutive fluorescence intensity and lifetime frames for the 450±20 nm 
channel are shown in Media 1 in the supplemental material. The lifetime maps clearly 
show longer lifetimes for the POPOP capillary (bottom) compared to the NADH capillary 
(top). To investigate the robustness of the imaging system to motion artifacts, the position 
of the capillaries was shifted at the 6th frame. While the intensity maps are not affected, 
the lifetime values are underestimated for part of the POPOP capillary during the shift in 
the capillary position; however, the lifetime maps are stabilized after one frame. 
4.3 Preclinical in vivo imaging of a hamster cheek pouch model of oral cancer 
The FLIM endoscope was further validated by imaging in vivo a lesion from a 
DMBA-treated hamster check pouch, which was diagnosed by histopathology as 
dysplasia. The imaging protocol for this study was approved by the Institutional Animal 
Care and Use Committee (IACUC) at Texas A&M University (TAMU). Multispectral 
FLIM images of the oral lesion surrounded by healthy tissue are displayed in Fig. 11, 
where it can be seen that the fluorescence intensity images have stronger fluorescence in 
the surrounding healthy tissue relative to the lesion area for all spectral channels. The 
fluorescence lifetime images for the 390±20 nm and 450±20 nm channels show longer 
values in the surrounding healthy tissue (~2-3 ns) relative to the lesion area (~1.2-1.6 ns), 
whereas for the 560±20nm channel, longer values in the lesion area (~1.6-1.7 ns) relative 
to the surrounding healthy tissue (~1.2-1.3 ns) can be seen. These fluorescence intensity 
and lifetime values in the lesion are similar to those of NADH and FAD, whereas the 
intensity and lifetime values of the surrounding healthy tissue suggest the presence of a 
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collagen rich area. These results are also consistent with the biochemical composition of 
normal and cancerous epithelial tissue.  
Continuous multispectral FLIM imaging was also demonstrated in vivo on the same 
hamster cheek pouch lesion. A total of ten consecutive fluorescence intensity and lifetime 
frames for the three spectral channels are shown in Media 2 in the supplemental material. 
 
Figure 11: In vivo imaging of a DMBA-treated hamster cheek pouch. (A) Fluorescence 
intensity maps (B) Lifetime maps (colorscale in ns). The arrows indicate a small 
malignant lesion showing distinct fluorescence intensity and lifetime values than those 
from the surrounding tissue.  
 
4.4 Discussion 
Our in vitro and in vivo results clearly demonstrate that simultaneous multispectral 
FLIM imaging can be implemented using the spectral separation scheme proposed in our 
endoscope design. This flexible FLIM endoscope represents the first design in which both 
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UV illumination and visible (VIS) fluorescence emission can be transmitted through the 
same optical path. Although its compact design and fast imaging speed is suitable for 
clinical application, it suffers from two main disadvantages. First, while the fiber bundle 
used in this study is the most flexible commercially available bundle with adequate 
transmission in the UV-VIS range with the added advantage of low UV-induced 
autofluorescence, its flexibility (minimum bending radius of 200mm) is still far from ideal 
for many clinical applications. In the future, it is quite possible that more flexible imaging 
bundles will be custom-fabricated for subsequent designs. For applications where UV 
illumination is not critical, other more flexible imaging bundles are already commercially 
available. Second, the fast imaging speed (1 fps) is achieved by utilizing RLD algorithm 
which only requires two gates for lifetime calculation. The relatively poor temporal 
resolution of this method may not provide sufficient contrast to detect and differentiate 
normal, precancer and cancer. To overcome the second disadvantage, we adopted pulse 
sampling implementation with MCP-PMT instead of ICCD as described in the following 
chapters. 
4.5 Conclusion  
We have presented a compact flexible FLIM endoscope system based on a coherent 
optical fiber bundle suitable for both UV excitation and VIS collection. This system is 
capable of continuous lifetime imaging for up to three fluorescence emission bands 
simultaneously.  This novel endoscope design was validated by standard fluorescent dyes 
and a dysplasia lesion from a DMBA-treated hamster cheek pouch. Although it is compact 
and fast enough for in vivo application, the disadvantages discussed in Section 4.4 make 
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us continue to design another probe based on pulse sampling implementation for the 
following clinical trial. The new endoscope design will be described in the following 
chapters.  
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5. RIGID HANDHELD MULTISPECTRAL FLIM ENDOSCOPE 
5.1 Rigid handheld multispectral FLIM endoscope system 
In the previous chapter, we described the design of a fiber bundle based endoscope 
and discussed its limitations. To overcome these disadvantages, a rigid handheld FLIM 
endoscope was designed [33]. The system was based on time-domain pulse sampling 
implementation, similar to the bench-top FLIM system in Chapter 3. 
The system consists of a handheld box (volume: 7×13×5 cm3, mass: 450 g) fitted 
with a custom-designed rigid endoscope (length: 14 cm, diameter: 1.7 cm) as shown in 
Fig. 12 (a). The schematic of the proposed system is shown in Fig. 12 (b). A frequency-
tripled Q-switched Nd:YAG laser (355 nm, <1 ns pulse width, 100 kHz maximum 
repetition rate, Advanced Optical Technology) was used as the excitation source. A 
multimode fiber with core diameter of 25µm (0.10 NA, HPSC25, Thorlabs) or 50 µm 
(0.22 NA, FVP050055065, Polymicro Technologies) delivered the excitation light to the 
handheld box. The excitation light was collimated (L2: f = 11 mm, ARC 350-700 nm, 
CFC-11X-A, Thorlabs) and scanned by a pair of galvonometer mirrors (5 mm beam 
aperture, ±5 mechanical degrees, Cambridge Technology) on the proximal end of the rigid 
endoscope. The rigid endoscope was built using standard ½” lens tubes (Thorlabs) and 
consisted of three lenses. The first two lenses (L3, L4: f = 30 mm, LB003, Thorlabs) 
worked as an image relay to extend the length of the endoscope, while the third lens (L4: 
                                                 
 Reprinted with permission from “Handheld multispectral fluorescence lifetime imaging system for in 
vivo applications” by Cheng S., Cuenca R.M., Liu B., Malik B.H., Jabbour J.M., Maitland K.C., Wright J., 
Cheng Y-S.L., Jo J.A., 2014. Biomedical Optics Express, 5(3), p. 921-931, Copyright [2014] by The 
Optical Society. 
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Near UV achromat doublet, f = 30 mm, 50 mm or 60 mm; Edmund Optics) worked as an 
objective to focus the light on the sample. In this configuration, the excitation fiber core 
diameter and the focal length of the objective determined the lateral resolution and the 
FOV of the system.  A lens tube with a length equal to the objective’s focal length was 
added at the distal end of the probe which allowed the sample to be in contact with the 
probe, which can help reduce motion artifact during in vivo imaging.  
 
Figure 12: (a) Phtograph of the handheld rigid endoscope (b) Schematic of the rigid 
FLIM endoscope system. DM: Dichroic mirror, L: Lens, F: Filter, AMP: Amplifier. 
 
An optical simulation of the rigid endoscope design was performed by Zemax 
(Radiant Zemax) as follows, results of which are presented in Fig. 13. The excitation 
wavelength for the simulation was set to 355 nm. The setup consisted of a point source 
(object NA=0.1), a collimator (f=11mm, CFC-11X-A, Thorlabs), a pair of mirror scanners 
(5 mm in diameter for active area) and the three-lens combination for the endoscope 
described above. In this configuration, we were able to simulate the FOV by changing the 
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scan angle of the mirror scanners. By using objective lens with focal lengths of 30mm, 
50mm and 60mm, we could vary the FOV. The three colors in Fig. 13 represent light 
coming from three different scanning angles. The Zemax simulation estimated the 
numerical aperture of the endoscope at ~0.028 and the maximum FOV of ~5 mm for 30 
mm focal length objective, ~10 mm for the 50 mm focal length objective and ~12 mm for 
the 60 mm focal length objective, which were close to the measured FOV. We also 
analyzed an intensity line profile across the features of a 1951 USAF resolution target to 
quantify the lateral resolution [34]. The intensity profile represented the edge-response 
function and its first-order derivative was the line-spread function (LSF) which was also 
the cross section of the lateral point spread function (PSF). As an example, for the 25 μm 
excitation fiber and the 50 mm focal length objective, the FWHM of the PSF was 
calculated to be 44.8 um, which was in close agreement with the corresponding value 
experimentally determined by imaging the USAF resolution target as shown in Table 3. 
Table 3 also provides FOV and lateral resolution values for different combinations of fiber 
core size and objective’s focal length. 
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Figure 13: Zemax simulation for the excitation optical pathway. Different colors 
represent light from different scan angles. 
 
Table 3 Comparison of resolution and FOV with different focal length objectives and 
excitation fiber core diameters 
Excitation fiber core 
diameter 
( µm) 
Objective focal length 
( mm) 
Lateral resolution 
( µm) 
FOV diameter 
(mm) 
25  
f=30  ~35  ~6.5 
f=50  ~50  ~11  
f=60  ~88  ~13  
50  
f=30  ~70  ~6.5  
f=50  ~110  ~11  
f=60  ~140 ~13  
 
The time-resolved fluorescence emission was spectrally divided in three separate 
emission bands by the same detection unit as described in Chapter 3. Briefly, as shown in 
Fig. 12 (b), a set of dichroic mirrors (DM2, DM3) and filters (F1-F3) separated the 
emission into three spectral bands, each one was coupled into one of the three multimode 
fiber with different lengths. Thus, for a single excitation pulse, multiple decays 
corresponding to different spectral bands could be recorded using a single detector. The 
spectral bands could be customized based on the targeted fluorophores.  We selected the 
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390±20 nm, 452±22.5 nm, and >500 nm bands to optimally distinguish emission from 
three tissue endogenous fluorophores: collagen, NADH, and FAD, respectively. The 
multispectral fluorescence signal was detected by a multichannel plate photomultiplier 
tube (MCP-PMT, 25 ps transient time spread, R3809U-50, Hamamatsu), followed by a 
preamplifier before being digitized at 6.25 GS/s by a high-speed digitizer (PXIe-5185, 
National Instruments) resulting in a temporal resolution of 320 ps. 
FLIM data obtained from the proposed design was processed using the methods 
described in Chapter 3. For each sample, nine maps were generated: three absolute 
intensity maps (I1, I2 and I3), three normalized intensity maps (I1n, I2n and I3n) and three 
average lifetime maps (τ1, τ2 and τ3). For average lifetime calculation, the relatively broad 
excitation pulse width (FWHM: ~1 ns) necessitated the temporal deconvolution of the 
instrument response from the measured fluorescence decay in order to obtain accurate 
estimation of the fluorescence lifetime. Time deconvolution was performed offline using 
an optimized Laguerre expansion technique algorithm [24]. The average lifetime τave was 
then estimated from the intrinsic fluorescence decay h(t) using the formula 
( ) ( )ave t h t h t    , where t is time. Besides the offline lifetime estimation, in order to 
demonstrate real-time visualization of the multispectral FLIM results, an online 
deconvolution method was applied, in which the recorded time-resolved decay for each 
pixel was compared against a lookup table of decays generated by convolving the 
instrument response with single exponential decays with time constants ranging from 0.2 
to 8 ns (in steps of 0.2 ns). The best match in terms of the minimum normalized means 
squared error provided a single exponential estimation of the fluorescence lifetime. 
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For all the experiments in this chapter, the following parameters were used. The laser 
pulse energy at the sample was set at ~1 µJ/pulse, resulting in an adequate signal-to-noise 
ratio (SNR ≥ 30 dB). Since only one pulse was required per pixel, the pixel rate was equal 
to the laser repetition rate. The laser repetition rate was set at 30 kHz and the total number 
of pixels per frame was set at 150150, corresponding to a frame rate of ~1.33 Hz. The 
combination of an excitation fiber with a core diameter of 50 µm and an objective with a 
focal length of 50 mm were adopted, which provided a FOV of ~10mm and a lateral 
resolution of ~110µm. This FOV and resolution were suitable for imaging oral cancer. 
5.2 Standard dyes validation 
The handheld imaging system was first validated with 1 mM solutions of POPOP (in 
ethanol), NADH and FAD (in PBS). The standard dye solutions were loaded in three 
quartz capillary tubes and placed side by side under the probe.  
The normalized intensity maps (Fig. 14 (a)) confirm strong emission of POPOP at 
both the 390 nm and 452 nm channels, strongest emission of NADH at the 452 nm 
channel, and emission of FAD only at the >500 nm channel. The average lifetime maps 
(Fig. 14 (b)) are also in good agreement with the previously published values for the 
corresponding fluorophores [24, 32]. The average lifetimes are 1.26 ± 0.05 ns, 0.67± 0.06 
ns and 2.75± 0.03 ns for POPOP, NADH and FAD, respectively. 
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Figure 14: In vitro imaging of quartz capillaries loaded with FAD, NADH, and POPOP. 
(a) Normalized fluorescence intensity maps, and (b) Fluorescence lifetime maps. 
 
In order to demonstrate the system’s potential for in vivo applications, continuous 
multispectral imaging was conducted at ~1.33 frames per second. A video, named Media 
3 in the supplemental material, was recorded with the online lifetime estimation. The 
average lifetime values for the dyes using the offline and the online methods are compared 
in Table 4 (calculated pixel-to-pixel for the areas corresponding to the entire capillary). 
The offline method provides smaller values than the online method, which is expected 
because of the assumption for online estimation that the fluorescence decays followed 
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single exponential decays. But the lifetime value calculated from online method does 
provide contrast among three fluorescent dyes. 
All the videos showed in this chapter were processed with this online method, 
whereas all the figures in this chapter were processed offline with the Laguerre 
deconvolution algorithm. 
 
Table 4 Comparison of offline and online fluorescence lifetime estimation  
(mean ±standard deviation) 
 Offline Estimates (ns) Online Estimates (ns) 
POPOP (390 nm) 1.26 ± 0.07 1.03 ± 0.13 
NADH (452 nm) 0.67 ± 0.04 0.32 ± 0.08 
FAD (>500 nm) 2.75 ± 0.03 1.91 ± 0.14 
Pouch (390 nm) 5.86 ± 0.17 3.91 ± 0.58 
Pouch (452 nm) 4.44 ± 0.13 2.36 ± 0.45 
Pouch (>500 nm) 3.40 ± 0.19 1.92 ± 0.41 
 
5.3 Normal hamster cheek pouch imaging in vivo 
To demonstrate the ability for in vivo application, the handheld system was validated 
by imaging a normal hamster cheek pouch in vivo. The imaging protocol was approved by 
the IACUC at TAMU. During imaging, the hamster was first anesthetized, a cheek pouch 
was pulled out and extended, and the rigid probe was gently placed on the mucosa surface.  
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Figure 15: In vivo imaging of a normal hamster cheek pouch. (a) Absolute fluorescence 
intensity maps, (b) Normalized fluorescence intensity maps, and (c) Fluorescence 
lifetime maps. 
 
Results from an imaged region are shown in Fig. 15. The FLIM maps indicate strong 
fluorescence intensity at the 390 nm and 452 nm channels (Fig. 15 (a) - (b)), and lifetime 
values between 4-6 ns (Fig. 15 (c)), reflecting a collagen-dominant autofluorescence 
expected in normal epithelial tissue. Notice that the vasculature network can be observed 
in the absolute fluorescence intensity maps, as blood absorption attenuated the 
fluorescence signal. The normalized intensity and lifetime maps, on the other hand, are 
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insensitive to blood absorption, and indicate spatially uniform spectral and lifetime 
properties of the autofluorescence emission of the normal epithelial tissue of a hamster 
cheek pouch. This is expected, since both the layered structure and the relative 
concentration of endogenous fluorophores (NADH and FAD in the epithelium, and 
collagen in the underlying stroma) are maintained throughout the normal epithelial tissue.  
A video, named Media 4 in the supplemental material, was recorded during the 
movement of the probe on top of the mucosa tissue with the real-time online data 
processing at ~1.33 frames per second. The average lifetimes using either offline or online 
method are compared in Table 4. In the table, the number are calculated pixel-to-pixel for 
the area corresponding to the entire FOV. The online method provides smaller values than 
the offline method, which is expected. But these values does provide a contrast among the 
different fluorescent components (collagen, NADH and FAD) in epithelial tissue. 
5.4 Human oral biopsy imaging ex vivo 
The clinical potential of this system was further demonstrated by imaging human oral 
biopsies ex vivo. The respective imaging protocols were approved by the Institutional 
Review Boards (IRB) at TAMU and Baylor College of Dentistry. Tissue samples were 
obtained from consenting patients who presented themselves either for removal of 
clinically normal excess tissue or were suspected to have benign, premalignant or 
malignant lesions. After extraction, the tissue was immediately placed in iced phosphate 
buffered saline (PBS) solution and transported to the imaging system within 10 minutes. 
During imaging, the tissue samples were placed in a quartz petri dish. A single FLIM 
image was recorded with the epithelium in contact with the probe distal end. One part of 
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the biopsy was sutured to mark the image orientation to allow comparison with the 
respective histology section. Finally, the tissue specimen was fixed in 10% formalin and 
processed for hematoxylin and eosin (H&E) histological analysis. The whole procedure 
was performed within half an hour. Three different types of tissue were imaged, which 
were classified as normal, benign and premalignant tissue. The results are shown in Fig. 
16, Fig. 17 and Fig. 18, respectively.  
Fig. 16 shows the FLIM images from a clinically normal oral tissue. For the intensity 
maps, strong emission are observed at the 452 nm channel, followed by comparatively 
lower fluorescence at the 390 nm and >500 nm channels. The normalized intensity is 0.27 
± 0.08, 0.51 ± 0.05, and 0.23 ± 0.04 across the normalized intensity maps in Fig. 16 (b) 
for three spectral channels, respectively. The average lifetime is 4.84 ± 0.43 ns, 3.95 ± 
0.38 ns and 3.79 ± 0.28 ns across the lifetime maps in Fig. 16 (c) for the three spectral 
channels, which indicates collagen is the predominant fluorophore in the sample. 
Although the absolute fluorescence intensity maps in Fig. 16 (a) show variability across 
the area of the tissue, the corresponding normalized intensity and lifetime images are 
relatively uniform. The left border of the tissue has a region where the epithelium layer is 
absent and underlying connective tissue is exposed. As a result, the normalized intensity 
and average lifetime in that specific region are increased at the 390nm channel.  
Fig. 17 shows FLIM images taken from an oral biopsy of lichen planus, which is a 
benign inflammatory condition and is usually attributed to a form of autoimmune 
response. The maps are very similar to those from the normal tissue. The top region is also 
lack of epithelium layer, which gives variability across the field of view. 
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Fig. 18 shows FLIM images of an oral biopsy representative of premalignant tissue. 
The absolute intensity, normalized intensity and average lifetime maps are shown in Fig. 
18 (a), 18 (b), and 18 (c), respectively. For the intensity maps, strong emission is observed 
at the 452 nm channel, followed by comparatively lower fluorescence at the 390 nm and 
>500 nm channels. For the average lifetime maps, the 452 nm channel show relative 
shorter lifetime than 390 nm channel attributed to NADH, which show a short lifetime 
and peak emission at ~450 nm. While most of the FLIM parameters (intensity and lifetime) 
do not show significant variation across the biopsy, a small region (marked as Region 1 in 
Fig. 18 (c)) in the lifetime map for >500 nm channel shows a larger value of lifetime (5.19 
± 0.30 ns) in contrast to the rest of the biopsy. This area was later diagnosed as superficial 
invasive squamous cell carcinoma. The corresponding histology image is shown in Fig 18 
(d). For comparison, the histology image of a region which representes the rest area of this 
biopsy (marked as Region 2 in Fig. 18 (c)) with relatively lower lifetime values (4.03 ± 
0.19 ns) is shown in Fig. 18 (e). This particular region in Fig. 18 (e) was diagnosed as 
dysplasia as most of the biopsy. The increased lifetime in Region 1 can be attributed to 
poryphirin, the presence of which is known to increase with the progression of precancer 
and has a relatively long lifetime (>6 ns) [18]. 
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Figure 16: FLIM images of clinically normal tissue from gingiva. (a) Absolute 
fluorescence intensity (b) Normalized fluorescence intensity, and (c) Average lifetime 
maps for 390nm, 450nm and >500nm spectral channel, respectively. (d) Image of the 
corresponding histology section. 
100 μm 
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Figure 17: FLIM images of the benign lesion classified as oral lichen planus. (a) 
Absolute fluorescence intensity (b) Normalized fluorescence intensity, and (c) Average 
lifetime maps for 390nm, 450nm and >500nm spectral channel, respectively. (d) Image 
of the corresponding histology section. 
100 μm 
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Figure 18: FLIM images of the premalignant tissue. (a) Absolute integrated fluorescence 
intensity maps, (b) Normalized integrated fluorescence intensity maps, and (c) Aerage 
lifetime maps. The thread at the bottom of (a), (b) and (c) is the suture used to mark the 
tissue orientation for histology study. (d) Histology image for the position marked in (c) 
as Region 1 which was diagnosed as superficial invasive squamous cell carcinoma. (e) 
Histology image for the position marked in (c) as Region 2 which was diagnosed as 
dysplasia. Both Region 1 and Region 2 are squares of 600×600 μm2. The scale bars in 
both (d) and (e) represent 200μm. 
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5.5 Normal human oral mucosa imaging in vivo 
The system was further validated by imaging human oral mucosa from normal 
volunteers. The imaging protocols were approved by the Institutional Review Boards 
(IRB) at TAMU and Baylor College of Dentistry. The ventral surface of a normal human 
tongue was imaged in vivo. The probe was inserted into the volunteer’s month and gently 
placed on the target location. Only one frame was collected to minimize exposure to UV 
radiation. 
The absolute intensity, normalized intensity and average lifetime maps are shown in 
Fig. 19. Strong emission is observed in 452 nm channel, followed by comparatively lower 
fluorescence at 390 and >500 nm channels. The average lifetime maps show similar 
lifetime of 4.04±0.29 ns, 4.22±0.28 ns and 4.19±0.28 ns for 390 nm, 452 nm and >500 nm 
channels, respectively. Notice also here that spatial contrast is evident in the absolute 
fluorescence intensity maps, while little contrast is observed in the normalized intensity 
and lifetime maps, as expected for normal epithelial tissue.  
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Figure 19: In vivo imaging of the ventral tongue from a normal human volunteer. (a) 
Absolute integrated fluorescence intensity maps, (b) Normalized integrated fluorescence 
intensity maps, and (c) Fluorescence lifetime maps. 
 
5.6 Clinical validation in human subjects in vivo 
Patients with suspected lesion were included for this study. The diseased human oral 
mucosa was imaging in vivo. The imaging protocols were approved by the Institutional 
Review Boards (IRB) at TAMU and Baylor College of Dentistry. Only one frame was 
collected to minimize exposure to UV radiation. The laser power deposited on tissue 
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surface was calculated to be below the maximum permissible exposure (MPE) of the tissue 
damage threshold by referring the American National Standards Institute (ANSI) 
standards for the safe use of lasers on skin. The detailed calculation can be found in Section 
5.7. In order to facilitate this imaging process, the system was moved to bedside in the 
clinic. The patients were first inspected by physicians and the ones who were referred for 
a biopsy or oral surgery were asked whether they were willing to join our study. The 
consented patient was imaged in vivo by the physician on the lesion. After the in vivo 
imaging, the patient would be sent for either biopsy collection or oral surgery to remove 
part or the whole lesion where we did the in vivo imaging. The incised tissue was imaged 
ex vivo under our system as comparison and sent for H&E histological analysis.  
Fig. 20 and Fig. 21 show the results of the in vivo and ex vivo imaging for the same 
lesion of a patient. The absolute intensity, normalized intensity and average lifetime maps 
for in vivo imaging are shown in Fig. 20 (a), 20 (b), and 20 (c), respectively. For the 
intensity maps, strong emission is observed at the 452 nm channel, followed by 
comparatively lower fluorescence at the 390 nm and >500 nm channels. For the average 
lifetime maps, a change of lifetime is shown across the FOV in the 390 nm channel in Fig. 
20 (c). The left part which is normal tissue shows longer lifetime than the right part which 
was diagnosed as dysplasia by histologist. White arrows indicate the margin between the 
normal tissue and dysplasia tissue. The longer lifetime value suggests that the dominant 
fluorophore is collagen, and the shorter lifetime of dysplasia tissue can be attributed to the 
increase of NADH. These results are consistent with the biochemical composition of 
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normal and dysplasia tissue. The average lifetime for the right part in 390 nm channel is 
4.02±0.28 ns in contrast to 2.70±0.27 ns for the left part. 
For comparison, the biopsy taken from the same lesion was imaged ex vivo. The 
absolute intensity, normalized intensity and average lifetime maps for ex vivo imaging are 
shown in Fig. 21 (a), 21 (b), and 21 (c), respectively. For the intensity maps, strong 
emission is observed at the 452 nm channel, followed by comparatively lower 
fluorescence at the 390 nm and >500 nm channels. For the average lifetime maps, a change 
of lifetime is shown in the 390 nm channel in Fig. 21 (c), in which the center part shows 
a shorter lifetime than the rest of the tissue. This specific region with shorter lifetime 
corresponds to the left part of the tissue in Fig. 20 (c), was histopathologically diagnosis 
as dysplasia (histology image shown in Fig. 21 (d)). White arrows indicate the same 
margin between the normal tissue and dysplasia tissue as in Fig. 20 (c). The shorter 
average lifetime in 390 nm channel is 3.08±0.26 ns in contrast to 4.62±0.26 ns of the 
longer average lifetime, which are in agreement with the results from the in vivo imaging. 
In addition, the absolute intensity maps of Fig. 20 (a) and Fig. 21 (a) also show similar 
structure for in vivo imaging and ex vivo imaging, which is also an indicator to correlate 
in vivo imaging and ex vivo imaging.  
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Figure 20: In vivo imaging of the dysplasia tissue. (a) Absolute integrated fluorescence 
intensity maps, (b) Normalized integrated fluorescence intensity maps, and (c) Average 
lifetime maps. White arrows show the margin between the normal and dysplasia tissue. 
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Figure 21: Ex vivo imaging of oral biopsy taken from the same lesion in Fig. 20. (a) 
Absolute integrated fluorescence intensity maps, (b) Normalized integrated fluorescence 
intensity maps, and (c) Average lifetime maps. White arrows show the margin between 
the normal and dysplasia tissue. 
 
 
5.7 Discussion 
As stated before, a pulse energy of 1 µJ at the sample provides an adequate SNR per 
pixel; thus, the pixel rate equates to the laser repetition rate. Since the frame rate is 
determined by the pixel rate and the number of pixels per frame, imaging speed can be 
increased by either increasing the laser repetition rate or decreasing the number of pixels 
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per frame. The number of pixels per frame can be reduced without sacrificing lateral 
resolution if the FOV is also reduced accordingly; thus, higher frame rates can be achieved 
at smaller FOV. Increasing the laser repetition rate while maintaining the pulse energy 
will increase the average power transmitted through the excitation fiber and ultimately 
deposited on the sample. Thus, the maximum average power that can be practically 
applied is ultimately limited by the damage threshold of both the excitation fiber and the 
sample. For all the experiments, the laser repetition rate was limited to 30 kHz in order to 
avoid rendering permanent damage to the input facet of the excitation fiber (observed at 
higher repetition rates). To increase the frame rate, the use of other excitation fibers 
capable of handling higher average power levels (thus higher pixel rate) is currently being 
explored. 
The tissue damage threshold can be estimated in terms of the maximum permissible 
exposure (MPE) provided by the American National Standards Institute (ANSI) standards 
for the safe use of lasers on skin [35]. Since the excitation we use is a repetitive-pulse 
laser. There are two rules to follow: the exposure of the skin shall not exceed the MPE 
based upon a single-pulse exposure, and the average irradiance of the pulse train shall not 
exceed the MPE applicable for the total pulse train. In our case, the single-pulse limit for 
a 1 ns pulse exceeds 300 µJ in the limiting aperture (φ = 3.5 mm) which is much higher 
than the energy we use. As a result, we will be limited by the total energy deposited over 
the dwell time. According to the standard, there are thermal and photochemical effects, 
between which the smaller MPE value should be follow. According to the standard, the 
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thermal MPE yields smaller value. The equation to calculate the thermal MPE is in Eq. 
5.1 
                                              𝑀𝑃𝐸 = 0.56 𝑡0.25 (𝐽/𝑐𝑚2)                                          (5.1) 
It is defined in a limiting aperture φ = 3.5 mm. The equation should be modified as in Eq. 
5.2 if the aperture are is considered. 
                     𝑀𝑃𝐸 = 0.56 × 𝜋 𝑟2𝑡0.25 = 0.56 × (3.14) × (0.175)2 × 𝑡0.25 (𝐽)     (5.2) 
The dwell time t in Eq. 5.1 and Eq. 5.2 is equal to s/f, where s is the total number of pulses 
applied inside the limiting aperture, and f is the laser repetition rate. Since only one pulse 
is applied per pixel, s equates to the total number of pixels inside the limiting aperture. In 
our in vivo experiments, the laser repetition rate was 30 kHz with a pulse energy of ~1 μJ, 
and the number of pixels per frame was set at 150 × 150 for a FOV of 10 × 10 mm2. Thus, 
based on the Eq. 5.2, the MPE is E (J) = 5.39 × 10-2 × (s/f) 0.25 = 5.39 × 10-2× (2164 / 
30,000) 0.25 = 27.9 mJ. The actual energy deposited is E (J) = 53 × 53× 10-3 mJ = 2.2 mJ, 
which is an order of magnitude lower than the MPE. We are thus confident that in vivo 
imaging can be performed safely with the proposed handheld FLIM imaging system. 
One significant advantage of the proposed multispectral FLIM probe design is that, 
unlike previous implementations [8-10, 27], it can achieve relatively high imaging speed 
without sacrificing temporal resolution. The achieved high temporal resolution allows 
correcting for the non-ideal instrument response through time deconvolution. In addition, 
since the entire fluorescence decay is directly measured, the full complexity of its temporal 
dynamics can be captured and is no longer limited to a single exponential approximation.  
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Although our imaging systems allows measuring time-resolved fluorescence data 
with high temporal resolution, accurate estimation of fluorescence lifetimes still requires 
computationally expensive iterative deconvolution methods. Our fully validated Laguerre 
deconvolution method is significantly faster than standard nonlinear least square 
deconvolution algorithms, but it is still not suitable for online processing and visualization 
of FLIM data [24]. To take advantage of the relative high pixel rate achieved by our system 
and to demonstrate real-time FLIM data processing and visualization (as shown in Media 
3 and Media 4 in the supplemental material), the online deconvolution method described 
above was proposed. An interesting observation was the fact that the online processing 
and visualization of the multispectral FLIM maps were insensitive to movement (as shown 
in the videos). In Table 4, the values of the online lifetime estimations are compared 
against the offline estimations obtained with the Laguerre deconvolution method. As 
expected, the online values were underestimated with respect to the offline values due to 
the single exponential approximation. Nevertheless, the online FLIM maps provided 
fluorescence lifetime contrast similar to that of the offline FLIM maps. 
While the >500 nm emission band was provided to target and isolate fluorescence 
from FAD, there can be a significant contribution of fluorescence from poryphrin in 
precancerous and cancerous areas, and can potentially confound the signal in that band. 
The presence of poryphrin is usually attributed to changes associated with malignant 
transformation, and wherein the level of poryphrin is usually elevated in the effected tissue 
[36]. In our study, the effect of poryphrin manifested in Fig. 18 where the fluorescence 
lifetime in the region with invasive carcinoma showed a relative increase due to longer 
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lifetime of poryphrin [36]. For the future, we will consider adding another emission 
window corresponding to poryphrin (peak emission: ~630 nm). In addition to isolating 
fluorescence from FAD, adding of fourth spectral window can offer us another parameter 
to characterize the progression of precancer.  
As mentioned above, our target application was to image the oral mucosa in vivo. 
Our clinical collaborators (Dr. Lisa Cheng and Dr. John Wright) have indicated that the 
length of our current endoscope (14 cm) is appropriate to image the oral cavity, as we have 
successfully imaged a lot of patients in vivo. Nevertheless, the doctors indicated an 
endoscope design with even smaller size and less weight would be more convenient for 
handling and easily to access some specific narrow location inside the oral cavity 
according to their experience to operate the current system.  
5.8 Conclusion 
In summary, we reported the first demonstration of a time-domain multispectral 
FLIM endoscope that required only one excitation pulse per pixel; thus, the pixel rate was 
equal to the laser repetition rate. Taking advantage of this relatively high pixel rate, we 
were able to perform the fastest in vivo multispectral FLIM imaging in the human oral 
cavity reported thus far. Finally, we also reported the first demonstration of real-time 
deconvolution of the instrument response from the fluorescence decay at each pixel of the 
image, which allowed real-time lifetime map estimation and visualization at multiple 
spectral bands simultaneously. This design will facilitate the evaluation of multispectral 
FLIM for detecting oral cancer and precancer. 
 69 
 
 6. CLINICAL PROTOTYPE OF RIGID HANDHELD FLIM ENDOSCOPE 
6.1 Clinical prototype of rigid handheld FLIM endoscope 
As described in Section 5.7, reducing the size and the weight of the handheld system 
can potentially aid in probing most of the oral cavity in vivo. To this end, we constructed 
a relatively smaller version of the rigid handheld FLIM system with MEMS scanning 
mirrors and lenses with smaller diameters (6.25mm in diameter). This system will be 
served as the clinical prototype for in vivo study in the future. A photograph of the 
handheld part of the new system is shown in Fig. 22 (a). It was approximately 250 gram 
in weight with a handheld package of 10 × 5 × 3 cm3 in volume. A rigid probe (length: 
11cm, diameter: 0.8cm) was fitted onto the handheld package. The system schematic is 
shown in Fig. 22 (b). Pulsed UV excitation light from a frequency-tripled Q-switched 
Nd:YAG laser (355 nm, <1 ns pulse width, 100 kHz maximum repetition rate, Advanced 
Optical Technology) was delivered to the system through a multimode fiber (50µm core 
diameter, FG050LGA, Thorlabs), and collimated by an aspherical lens (f = 8mm, 
A240TM-A, Thorlabs). The collimated excitation was reflected by a dichroic mirror (1/2 
inch diameter, 377drz, Chroma) which was used to separate the UV excitation and visible 
fluorescence emission, and deflected by a two dimensional MEMS scanning mirror 
(4.2mm active area, -5° to +5° mechanical angle, Mirrorcle) onto the rigid probe. The 
dichroic mirror and MEMS scanning mirror were mounted at a 45° angle to the incoming 
excitation light in a custom-machined housing. A three-adjuster kinematic mirror mount 
(KCB05, Thorlabs) was integrated in the housing to mount the dichoric mirror. It allowed 
slight angle adjustment in order to compensate for any inaccuracies introduced during 
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machining of the housing. The housing was made from aluminum. The rigid probe was 
custom-designed with four achromat lenses (f = 30 mm, 6.25 mm diameter, Edmund 
Optics). Two of these lenses formed an image relay to extend the length of the probe as 
described in the previous handheld system. Another lens at the distal end worked as an 
objective to focus the light onto the sample. A fourth lens was placed in the intermediate 
image plane of the relay lens pair to serve as a field lens which increased the FOV from 
~3.6 mm to ~5 mm. Fig. 23 shows the Zemax simulation for the rigid probe both with and 
without the field lens. The three colors in Fig. 23 represent three different scanning angles. 
As seen in the three-lens system, the marginal light is out of the range of the second lens 
of the relay lens pair. After adding the field lens between the relay lens pair, the clipping 
of beam at the edge is eliminated. As a result, the scan angle is enlarged after adding the 
field lens.  
To assemble the probe, the four lenses were fixed with UV cured glue (NOV 63, 
Edmund Optics) inside a tube (Inner diameter = 6.35 mm, outer diameter = 7.14mm, 
McMaster Carr). The distance between the lenses should be decided by Zemax simulation 
and free-space test in order to optimize the optical performance of the probe. Small slits 
were made in specific positions on the tube to apply the UV glue. An outer tube (inner 
diameter = 7.41mm, outer diameter = 7.93mm, McMaster Carr) was used to seal the probe.  
The fluorescence emission was collected by the same rigid probe, de-scanned by the 
MEMS mirror and passed the dichroic mirror (DM1 in Fig. 22(b)) to the multispectral 
detection unit which was the same as described in Section 3.1 and Section 5.1. The time-
resolved fluorescence emission was spectrally divided in three separate emission bands: 
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390±20 nm, 452±22.5 nm, and >500 nm bands corresponding to peak emission 
wavelength of endogenous fluorophores of collagen, NADH and FAD, respectively. The 
multispectral fluorescence signal was detected by a multichannel plate photomultiplier 
tube (MCP-PMT, 25 ps transient time spread, R3809U-50, Hamamatsu), followed by a 
preamplifier before being digitized at 6.25 GS/s by a high-speed digitizer (PXIe-5185, 
National Instruments) resulting in a temporal resolution of 320 ps. 
 
Figure 22: (a) Photograph of the clinical prototype of the handheld probe (b) Schematic 
of the clinical prototype of the FLIM endoscope system. DM: Dichroic mirror, L: Lens, 
F: Filter, AMP: Amplifier. 
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Figure 23: Zemax simulation of the FOV (top) before adding the field lens and (bottom) 
after adding the field lens. 
 
Data processing was similar to that described in Chapter 3 and Chapter 5. For each 
sample, nine maps were generated: three absolute intensity maps (I1, I2 and I3), three 
normalized intensity maps (I1n, I2n and I3n) and three average lifetime maps (τ1, τ2 and τ3). 
For average lifetime calculation, the relatively long excitation pulse width (FWHM: ~1 
ns) necessitated the temporal deconvolution of the instrument response from the measured 
fluorescence decay in order to obtain accurate estimation of the fluorescence lifetime. 
Time deconvolution was performed offline using an optimized Laguerre expansion 
technique algorithm [24]. The average lifetime τave was then estimated from the intrinsic 
fluorescence decay h(t) with ( ) ( )ave t h t h t    , where t was time. Besides the offline 
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lifetime estimation, in order to demonstrate real-time visualization of the multispectral 
FLIM maps, an online deconvolution method was applied, in which the recorded time-
resolved decay for each pixel was compared against a lookup table of decays generated 
by convolving the instrument response with single exponential decays with time constants 
ranging from 0.2 to 8 ns (in steps of 0.2 ns). The best match in terms of the minimum 
normalized means squared error provided a single exponential estimation of the 
fluorescence lifetime. 
For all the experiments in this chapter, the following working parameters were used. 
The laser pulse energy at the sample was set at ~1 µJ/pulse, resulting in an adequate signal-
to-noise ratio (SNR ≥ 30 dB). Since only one pulse was required per pixel, the pixel rate 
was equal to the laser repetition rate. The laser repetition rate was set at 10 kHz and the 
total number of pixels per frame was set at 160160, corresponding to an acquisition 
speed of ~0.4 Hz. The lateral resolution was measured to be ~100 μm by USAF target 
(#53715, Edmund Optics). 
6.2 Standard dyes validation 
The new handheld imaging system was first validated with 1 mM solutions of 
POPOP (in ethanol), NADH and FAD (in PBS). The standard dye solutions were loaded 
in three quartz capillary tubes and placed side by side under the probe.  
The normalized intensity maps (Fig. 24 (a)) confirm strong emission of POPOP at 
both the 390 nm and 452 nm channels, strongest emission of NADH at the 452 nm 
channel, and emission of FAD only at the >500 nm channel. The average lifetime maps 
(Fig. 24 (b)) are also in good agreement with the previously published values for the 
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corresponding fluorophores [24, 27, 33].  The average lifetime for POPOP is 1.23±0.03 
ns for 390 nm channel and 1.12±0.02 ns for 452 nm channel. The average lifetime for 
NADH is 0.30±0.05 ns for 452 nm channel and 0.21±0.09 ns for >500 nm. The average 
lifetime for FAD is 2.14±0.05 ns for >500 nm channel.  
 
Figure 24: In vitro imaging of quartz capillaries loaded with FAD, NADH, and POPOP. 
(a) Normalized fluorescence intensity maps, and (b) Fluorescence lifetime maps. 
 
 
(a) 
(b) 
(c) 
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6.3 Normal human oral mucosa imaging in vivo 
The system was validated by imaging human oral mucosa in vivo from normal 
volunteers. The imaging protocols were approved by the Institutional Review Boards 
(IRB) at TAMU and Baylor College of Dentistry. The ventral surface of a normal human 
tongue was imaged in vivo. The probe was inserted into the volunteer’s month and gently 
placed on the target location. Only one frame was collected to minimize exposure to UV 
radiation. 
The absolute intensity, normalized intensity and average lifetime maps are shown in 
Fig. 25. Strong emission is observed in 452 nm channel, followed by comparatively lower 
fluorescence at 390 and >500 nm channels. The average lifetime maps show similar 
lifetime of 4.12±0.20 ns, 4.12±0.24 ns and 3.66±0.17 ns for 390 nm, 452 nm and >500 nm 
channels, respectively. Notice also here that spatial contrast is evident in the absolute 
fluorescence intensity maps, while little contrast is observed in the normalized intensity 
and lifetime maps, as expected for normal epithelial tissue.  
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Figure 25: In vivo imaging of the ventral tongue from a normal human volunteer. (a) 
Absolute integrated fluorescence intensity maps, (b) Normalized integrated fluorescence 
intensity maps, and (c) Fluorescence lifetime maps. 
 
6.4 Oral biopsy imaging ex vivo 
Fig. 26 shows FLIM images of a tissue biopsy. The absolute intensity, normalized 
intensity and average lifetime maps are shown in Fig. 26 (a), Fig. 26 (b), and Fig. 26 (c), 
respectively. For the intensity maps, strong emission is observed at the 452 nm channel, 
followed by comparatively lower fluorescence at the 390 nm and >500 nm channels. For 
(a) 
(b) 
(c) 
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the average lifetime maps, the 452 nm channel shows relative shorter lifetime than the 390 
nm channel attributed to NADH, which shows a short lifetime and peak emission at ~450 
nm. This indicates collagen is the predominant fluorophore in the sample which is similar 
to that in normal tissue or a benign lesion. At first, this lesion was clinically diagnosed as 
dysplasia and/or squamous cell carcinoma by visual inspection and palpation. Later 
histopathological diagnosis indicated that it was not premalignant or malignant but a 
hyperorthokeratosis and chronic mucositis, which was benign lesion and inflammatory. 
The histopathological diagnosis is in good agreement with our FLIM results.  
6.5 Discussion and conclusion 
As described in Chapter 5.7, the total energy deposited over the whole field of view 
should be smaller than the maximum permissible exposure (MPE) provided by the 
American National Standards Institute (ANSI) standards for the safe use of lasers on skin 
[35]. Based on Eq. 5.2, the MPE for this system is E (J) = 5.39 × 10-2 × (s/f)0.25= 5.39 × 
10-2× (9847 / 10,000) 0.25 = 53.7 mJ in a limited aperture of 3.5 mm. The actual energy 
deposited in an aperture of 3.5 mm is E (J) = 9847 × 10-3 mJ = 9.8 mJ, which is lower than 
the MPE. We are thus confident that in vivo imaging with one frame can be performed 
safely with the proposed handheld FLIM imaging system. The MPE is related to the pixel 
number per frame and the laser repetition rate. The MPE for different combinations of 
pixel number per frame and laser repetition rate is summarized in Table 5. 
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Figure 26: Ex vivo imaging of oral biopsy. (a) Absolute integrated fluorescence intensity 
maps, (b) Normalized integrated fluorescence intensity maps, and (c) Fluorescence 
lifetime maps. White arrows indicate a piece of hair on the tissue. 
 
In summary, we reported a compact multispectral FLIM endoscope system with rigid 
probe. This compact version of the handheld FLIM system can help access locations inside 
the oral cavity which may otherwise be difficult to reach with the larger probe described 
in previous chapter. We have validated the system with standard fluorescent dye, normal 
oral mucosa in vivo and human biopsy ex vivo. This design will be used as clinical 
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prototype for in vivo study in the future and it will facilitate the evaluation of multispectral 
FLIM for oral cancer and precancer detection. 
 
Table 5 Comparison table for the MPE and actual deposited energy with different laser 
repetition rate and pixel number per frame 
Pixel number per 
frame 
MPE Actual Energy 
10K 20K 30K  
80 × 80 38.0 mJ 31.9 mJ 28.8 mJ 2.4 mJ 
100 × 100 42.4 mJ 35.7 mJ 32.3 mJ 3.8 mJ 
160 × 160 53.7 mJ 45.1 mJ 40.8 mJ 9.8 mJ 
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7. CONCLUSION AND FUTURE WORK 
7.1 Conclusion 
In this dissertation, four specific aims were achieved: 
First, a bench-top combined FLIM-RCM system was built to determine specific 
design parameters for endoscope system and characterize the system’s performance for 
detection of oral precancer and cancer. Experiments on hamster cheek pouch model of 
oral carcinogenesis were conducted. Dysplastic and normal tissue were successfully 
differentiated. 
Second, a flexible endoscope based on a wide-field time-gated implementation was 
built. The system was validated by a hamster cheek pouch model of oral carcinogenesis. 
Due to the limitations of this setup, we continued to build a multispectral FLIM system 
based on pulse sampling implementation for in vivo application. 
Third, a rigid handheld probe based on pulse sampling was built. Clinical study of 
human oral tissue was conducted ex vivo and in vivo. 
Fourth, based on the feedback from the physicians who used the handheld FLIM 
system, a smaller version of the rigid handheld probe was built in order to easily operate 
and access most of the area inside the oral cavity. The system was validated by imaging 
normal human oral mucosa in vivo and oral biopsy ex vivo. 
7.2 Future work 
More compact design based on novel scanners can be achieved. One possible 
mechanism is employing a fiber scanner which holds and vibrates the fiber. This design is 
under investigation by our group. Besides, the dichroic mirror which is used to separate 
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excitation and emission light can be removed from the handheld box. If a fiber can be used 
to deliver excitation and emission, the dichroic mirror can be moved to the laser side as 
shown in Fig. 27. The handheld probe will be modified as a pen-shape device which will 
be more user-friendly. 
More in vivo and ex vivo imaging of human oral cancer and precancer need to be 
conducted in order to establish the database for quantitative analysis of the specificity and 
sensitivity of the FLIM system. 
 
Figure 27: (left) System schematic for the new proposed FLIM endoscope. (right) 
Photograph to show the appearance of the fiber scanner (FS). DM: Dichroic mirror, L: 
Lens, F: Filter, AMP: Amplifier. 
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